FI953916A - Fibrinogeenireseptoriantagonisteja - Google Patents

Fibrinogeenireseptoriantagonisteja Download PDF

Info

Publication number
FI953916A
FI953916A FI953916A FI953916A FI953916A FI 953916 A FI953916 A FI 953916A FI 953916 A FI953916 A FI 953916A FI 953916 A FI953916 A FI 953916A FI 953916 A FI953916 A FI 953916A
Authority
FI
Finland
Prior art keywords
fibrinogen
Prior art date
Application number
FI953916A
Other languages
English (en)
Swedish (sv)
Other versions
FI953916A0 (fi
Inventor
David Alan Claremon
John J Baldwin
Nigel Liverton
Ben Askew
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of FI953916A0 publication Critical patent/FI953916A0/fi
Publication of FI953916A publication Critical patent/FI953916A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A61K38/166—Streptokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
FI953916A 1993-02-22 1995-08-21 Fibrinogeenireseptoriantagonisteja FI953916A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2051793A 1993-02-22 1993-02-22
PCT/US1994/001881 WO1994018981A1 (en) 1993-02-22 1994-02-22 Fibrinogen receptor antagonists

Publications (2)

Publication Number Publication Date
FI953916A0 FI953916A0 (fi) 1995-08-21
FI953916A true FI953916A (fi) 1995-08-21

Family

ID=21799049

Family Applications (1)

Application Number Title Priority Date Filing Date
FI953916A FI953916A (fi) 1993-02-22 1995-08-21 Fibrinogeenireseptoriantagonisteja

Country Status (15)

Country Link
EP (1) EP0684823A4 (fi)
JP (1) JP3173792B2 (fi)
KR (1) KR960700722A (fi)
CN (1) CN1118139A (fi)
AU (1) AU680240B2 (fi)
BG (1) BG99863A (fi)
CA (1) CA2155123A1 (fi)
CZ (1) CZ210895A3 (fi)
FI (1) FI953916A (fi)
HU (1) HUT71796A (fi)
NO (1) NO953270L (fi)
NZ (1) NZ262664A (fi)
PL (1) PL310386A1 (fi)
SK (1) SK102495A3 (fi)
WO (1) WO1994018981A1 (fi)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849736A (en) * 1993-11-24 1998-12-15 The Dupont Merck Pharmaceutical Company Isoxazoline and isoxazole fibrinogen receptor antagonists
US5494921A (en) * 1994-09-16 1996-02-27 Merck & Co., Inc. Fibrinogen receptor antagonists
ZA963391B (en) * 1995-05-24 1997-10-29 Du Pont Merck Pharma Isoxazoline fibrinogen receptor antagonists.
US6100423A (en) * 1995-08-30 2000-08-08 G. D. Searle & Co. Amino benzenepropanoic acid compounds and derivatives thereof
ATE203234T1 (de) 1995-08-30 2001-08-15 Searle & Co Meta-guanidine, harnstoff, thioharnstoff oder azacyklische aminobenzoesäure-derivate als integrin antagonisten
US6291469B1 (en) 1995-09-29 2001-09-18 Eli Lilly And Company Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation
CA2240439A1 (en) * 1995-12-22 1997-07-03 The Dupont Merck Pharmaceutical Company Novel integrin receptor antagonists
WO1997035579A1 (en) * 1996-03-27 1997-10-02 Merck & Co., Inc. A method for inhibiting clot formation
EP0917462B1 (en) * 1996-07-25 2006-09-13 Biogen Idec MA Inc. Cell adhesion inhibitors
US5900414A (en) * 1996-08-29 1999-05-04 Merck & Co., Inc. Methods for administering integrin receptor antagonists
DE19653647A1 (de) * 1996-12-20 1998-06-25 Hoechst Ag Vitronectin - Rezeptorantagonisten, deren Herstellung sowie deren Verwendung
EP1023295A4 (en) * 1997-02-06 2001-01-24 Merck & Co Inc PRODUCTS BY FIBRINOGEN RECEPTOR ANTAGONISTS
WO1998043962A1 (en) * 1997-03-28 1998-10-08 Du Pont Pharmaceuticals Company Heterocyclic integrin inhibitor prodrugs
US6303625B1 (en) 1998-07-27 2001-10-16 Ortho-Mcneil Pharmaceutical, Inc. Triazolopyridines for the treatment of thrombosis disorders
DE60041584D1 (de) * 1999-07-28 2009-04-02 Aventis Pharma Inc Substituierte oxoazaheterozyclische verbindungen
AU2003301226A1 (en) * 2002-12-20 2004-07-22 Pharmacia Corp Acyclic pyrazole compounds for the inhibition of mitogen activated protein kinase-activated protein kinase-2
WO2008006540A1 (en) * 2006-07-12 2008-01-17 Syngenta Participations Ag Triazolopyridine derivatives as herbicides
WO2009137201A1 (en) * 2008-04-04 2009-11-12 Cv Therapeutics, Inc. Triazolopyridinone derivatives for use as stearoyl coa desaturase inhibitors
WO2010096722A1 (en) * 2009-02-20 2010-08-26 Takeda Pharmaceutical Company Limited 3-oxo-2, 3-dihydro- [1,2, 4] triazolo [4, 3-a]pyridines as soluble epoxide hydrolase (seh) inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5084466A (en) * 1989-01-31 1992-01-28 Hoffmann-La Roche Inc. Novel carboxamide pyridine compounds which have useful pharmaceutical utility
GB8913011D0 (en) * 1989-06-06 1989-07-26 Wellcome Found Anticonvulsant pyrazines
US5166154A (en) * 1989-10-17 1992-11-24 Boehringer Ingelheim Pharmaceuticals, Inc. Imidazo[1,2-a]piperazines
US5278161A (en) * 1990-06-28 1994-01-11 Hoffmann-La Roche Inc. Amino acid derivatives useful as renin inhibitors

Also Published As

Publication number Publication date
SK102495A3 (en) 1997-01-08
NO953270L (no) 1995-10-19
FI953916A0 (fi) 1995-08-21
WO1994018981A1 (en) 1994-09-01
KR960700722A (ko) 1996-02-24
CZ210895A3 (en) 1996-02-14
NZ262664A (en) 1997-04-24
BG99863A (en) 1996-02-29
EP0684823A4 (en) 1997-07-09
PL310386A1 (en) 1995-12-11
CN1118139A (zh) 1996-03-06
JPH08507072A (ja) 1996-07-30
HU9502028D0 (en) 1995-09-28
HUT71796A (en) 1996-02-28
EP0684823A1 (en) 1995-12-06
AU680240B2 (en) 1997-07-24
AU6246594A (en) 1994-09-14
NO953270D0 (no) 1995-08-21
CA2155123A1 (en) 1994-09-01
JP3173792B2 (ja) 2001-06-04

Similar Documents

Publication Publication Date Title
FI963267A0 (fi) Katalyyttinen kannin
FI953916A (fi) Fibrinogeenireseptoriantagonisteja
FI940154A (fi) Substituoidut dialkyylitioeetterit
FI934202A0 (fi) Kretskorthaollare foer elektronik-, el- och apparatinstallationslaodor
DE59403503D1 (de) Substituierte 1-Aryltriazolinone
FI932094A0 (fi) Kylningsapparat i kranens vaexel
FI932732A0 (fi) Rotorkonstruktion i en tvaolindningselektricitetsmaskin
FI934340A0 (fi) Foerfarande foer eldslaeckning
FI932264A0 (fi) Gapformare i en pappersmaskin
FI934567A0 (fi) Tvaett- och torkanlaeggning
FI932269A0 (fi) Maolningsanordning
BR9405830A (pt) Oxazois substituidos
FI930927A0 (fi) Banformningsparti i en pappersmaskin
FIU930479U0 (fi) Matbesticksset
DE69435311D1 (de) Geflügelfütteranlage
FI833U1 (fi) Dammfilter foer vaedringsluckor i foenster
FI1435U1 (fi) Foer synskadande avsett hjaelpdon i elspisvred
FI933617A0 (fi) Anordning i en stoetborrmaskin
FI935503A0 (fi) Elmotstaond i en sotlucka
FI933929A0 (fi) Anordning i matningsbalkens matningsmekanism foer en bergborrmaskin
FI934019A0 (fi) Foerfarande foer stoerningsmaetning i en basstation
FI933406A0 (fi) Glidyta foer farttagningsspaor i hoppbacke
SE9301675D0 (sv) Stensberg i
FI931520A0 (fi) Saekerhetssystem foer elspisar i hemhushaoll
FI934136A0 (fi) Lastoeverfoeringsanordning i vaexelflak

Legal Events

Date Code Title Description
FD Application lapsed